May 9th 2025
Poor API quality may often lead to delays in production and a shortage of supply.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
EMEA Recommends Two H1N1 Vaccines for Authorization
October 1st 2009On September 25, the European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommended the authorization of two vaccines for use in Europe against the H1N1 influenza: GlaxoSmithKline's (GSK) Pandemrix and Novartis's Focetria.
Bayer Receives Warning Letter for Alleged Deviations
September 24th 2009The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5, 2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active pharmaceutical ingredients (APIs).
The Advantages of Small-Format Equipment: A Q&A with Scott C. Garverick
September 16th 2009Small-format packaging equipment can provide benefits to the pharmaceutical industry such as quick changeover and low tooling costs. The machines also can shorten the time it takes to bring a product to the market.